American International Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-55,402
| Closed | -$1.82M | – | 899 |
|
|
2024
Q1 | $1.82M | Buy |
55,402
+640
| +1% | +$20.4K | 0.01% | 1048 |
|
|
2023
Q4 | $1.81M | Sell |
54,762
-221
| -0.4% | -$6.25K | 0.01% | 1026 |
|
|
2023
Q3 | $1.5M | Buy |
54,983
+1,955
| +4% | +$54.3K | 0.01% | 1049 |
|
|
2023
Q2 | $1.61M | Buy |
53,028
+13,460
| +34% | +$435K | 0.01% | 1027 |
|
|
2023
Q1 | $1.28M | Buy |
39,568
+788
| +2% | +$24.9K | 0.01% | 1110 |
|
|
2022
Q4 | $1.09M | Sell |
38,780
-142
| -0.4% | -$4.07K | 0.01% | 1173 |
|
|
2022
Q3 | $1.4M | Buy |
38,922
+551
| +1% | +$19.4K | 0.01% | 1045 |
|
|
2022
Q2 | $1.18M | Sell |
38,371
-1,211
| -3% | -$35.3K | 0.01% | 1135 |
|
|
2022
Q1 | $1.28M | Sell |
39,582
-2,786
| -7% | -$72.9K | 0.01% | 1198 |
|
|
2021
Q4 | $1.17M | Sell |
42,368
-58
| -0.1% | -$1.66K | 0.01% | 1330 |
|
|
2021
Q3 | $1.31M | Sell |
42,426
-1,008
| -2% | -$24.2K | 0.01% | 1276 |
|
|
2021
Q2 | $917 | Sell |
43,434
-570
| -1% | -$11.4K | ﹤0.01% | 1564 |
|
|
2021
Q1 | $889 | Buy |
44,004
+117
| +0.3% | +$2.23K | ﹤0.01% | 1525 |
|
|
2020
Q4 | $704 | Sell |
43,887
-1,260
| -3% | -$16.7K | ﹤0.01% | 1580 |
|
|
2020
Q3 | $560K | Sell |
45,147
-1,026
| -2% | -$12.1K | ﹤0.01% | 1540 |
|
|
2020
Q2 | $329K | Buy |
46,173
+2,323
| +5% | +$15.6K | ﹤0.01% | 1822 |
|
|
2020
Q1 | $238K | Sell |
43,850
-2,534
| -5% | -$22.6K | ﹤0.01% | 1810 |
|
|
2019
Q4 | $420K | Sell |
46,384
-390
| -0.8% | -$3.17K | ﹤0.01% | 1788 |
|
|
2019
Q3 | $336K | Buy |
46,774
+714
| +2% | +$5.12K | ﹤0.01% | 1868 |
|
|
2019
Q2 | $366K | Buy |
46,060
+2,591
| +6% | +$30.7K | ﹤0.01% | 1879 |
|
|
2019
Q1 | $547K | Sell |
43,469
-1,409
| -3% | -$22.3K | ﹤0.01% | 1647 |
|
|
2018
Q4 | $895K | Sell |
44,878
-345
| -0.8% | -$7.98K | ﹤0.01% | 1330 |
|
|
2018
Q3 | $1.28M | Buy |
45,223
+1,279
| +3% | +$30.5K | ﹤0.01% | 1278 |
|
|
2018
Q2 | $925K | Buy |
43,944
+5,731
| +15% | +$108K | ﹤0.01% | 1439 |
|
|
2018
Q1 | $545K | Sell |
38,213
-2,053
| -5% | -$29.4K | ﹤0.01% | 1660 |
|
|
2017
Q4 | $495K | Buy |
40,266
+5,335
| +15% | +$75.2K | ﹤0.01% | 1800 |
|
|
2017
Q3 | $622K | Buy |
34,931
+10,995
| +46% | +$227K | ﹤0.01% | 1627 |
|
|
2017
Q2 | $607K | Buy |
23,936
+14,533
| +155% | +$350K | ﹤0.01% | 1571 |
|
|
2017
Q1 | $210K | Buy |
9,403
+653
| +7% | +$12.5K | ﹤0.01% | 2157 |
|
|
2016
Q4 | $130K | Sell |
8,750
-24
| -0.3% | -$473 | ﹤0.01% | 2442 |
|
|
2016
Q3 | $216K | Buy |
8,774
+13
| +0.1% | +$304 | ﹤0.01% | 2118 |
|
|
2016
Q2 | $168K | Buy |
8,761
+1,134
| +15% | +$15.6K | ﹤0.01% | 2255 |
|
|
2016
Q1 | $81K | Buy |
+7,627
| New | +$78.8K | ﹤0.01% | 3579 |
|
Other funds holding EVH
RCM
EC
RSCM
EAM
American International Group's EVH Position: Q2 2024 in Review
American International Group sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 55,402 shares — an estimated $1.82M sold.
American International Group first reported a position in EVH in Q1 2016 and held it in 33 quarters. The position peaked at $1.82M in Q1 2024. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.
- American International Group reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
- American International Group sold 55,402 Evolent Health shares in Q2 2024, an estimated $1.82M.
- American International Group first reported a position in Evolent Health in Q1 2016 and held it in 33 quarters.
- American International Group's Evolent Health position peaked at $1.82M in Q1 2024.
- 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.